Evidence map›Paper›PMID 30625309›Full record

ArticleCell metabolism2019

A "Connexin" Responsible for the Fatal Attraction of Cancer to Bone.

David L Waning, Theresa A Guise, Khalid S Mohammad

Open access · bronzeAbstract readComment
In one paragraph

Article in Cell metabolism, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Muscle and Bone Defects in Metastatic Disease.Current osteoporosis reports · 2022
    Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

David L WaningPenn State College of Medicine, Department of Cellular and Molecular Physiology and Penn State Cancer Institute, Hershey, PA, USA.
Theresa A GuiseIndiana University School of Medicine, Department of Medicine and IU Simon Cancer Center, Indianapolis, IN, USA.
Khalid S MohammadIndiana University School of Medicine, Department of Medicine and IU Simon Cancer Center, Indianapolis, IN, USA. Electronic address: kmohamma@iu.edu.
Indiana University Health · USPenn State Milton S. Hershey Medical Center · US

Funding

(PQ#9)Targeting leaky ryanodine receptor (RyR2) to treat and prevent chemotherapy-associated cognitive dysfunction in patients with breast cancer.R01CA206025 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI GUISE, THERESA A, MARKS, ANDREW ROBERT · 2016 to 2020
$3.2M
(PQ9) Novel therapeutic approaches to chemotherapy-induced muscle.R21CA205437 · NCI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI WANING, DAVID L · 2016 to 2017
$372k
NCI NIH HHS R01 CA206025NCI NIH HHS R21 CA205437
6 · The paper itself

Abstract

Tumor cell interactions with the bone microenvironment are vital for the establishment and progression of bone metastases. Recently in Cancer Cell, Wang et al. (2018) showed that cells of the osteoblast lineage are critical for the delivery of calcium to tumor cells through gap junctions, pointing toward potential therapies for bone metastases.

Indexed as

CalciumNeoplasm MicrometastasisBone and BonesConnexinsGap JunctionsHumansOsteoblastsOsteogenesisTumor MicroenvironmentCalciumConnexins

Identifiers

PMID30625309
PMCPMC6443097
OpenAlexW2910948360

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.